Synergistic effect of polyoxometalates in combination with oxacillin against methicillin-resistant and vancomycin-resistant Staphylococcus aureus

a high initial inoculum of 1 × 108 cfu/ml for in vivo test

M. Inoue, T. Suzuki, Y. Fujita, M. Oda, N. Matsumoto, J. Iijima, T. Yamase

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Synergistic effect of polyoxometalates, K6[P2W18O62]·14H 2O (P2W18), K4[SiMo12O40]·3H2O (SiMo12), K7[PTi2W10O40]·6H 2O (PTi2W10), and K9H5[α-Ge2Ti6W18 O77]·16H2O (Ge2Ti6W18), in combination with a β-lactam oxacillin against methicillin-resistant and vancomycin-resistant Staphylococcus aureus (characterized by possessing the penicillin-binding protein 2′ (PBP2′) as a cell-wall synthesis enzyme) with a high initial inoculum of 1 × 108 cfu/ml (for in vivo test) was investigated with a help of the growth curve and the reverse transcription polymerase chain reaction (RT-PCR) analyses. The growth curves showing the suppression of cell proliferation of the strains based on the synergistic effect of the polyoxometalates in combination with oxacillin indicated a recovery of the cell proliferation during continuous cultivation. The duration of the suppression of the cell proliferation increased with increasing the concentration of the polyoxometalates, depending on the amounts of the initial inoculum of the strain. The RT-PCR results for P2W18, SiMo12, and PTi2W10 indicated the suppression of expression of the PBP2′-encoding mecA gene in contrast to the ones for Ge2Ti6W18. The difference in the RT-PCR results among the polyoxometalates suggests that there remain other factors for the inhibition of PBP2′ production such as post-transcription process.

Original languageEnglish
Pages (from-to)220-226
Number of pages7
JournalBiomedicine and Pharmacotherapy
Volume60
Issue number5
DOIs
Publication statusPublished - 2006 Jun
Externally publishedYes

Fingerprint

Penicillin-Binding Proteins
Oxacillin
Reverse Transcription
Cell Proliferation
Polymerase Chain Reaction
Lactams
Methicillin Resistance
Vancomycin
Growth
Cell Wall
Enzymes
Genes

Keywords

  • High initial inoculum
  • MRSA
  • Polyoxometalates
  • VRSA

ASJC Scopus subject areas

  • Pharmacology

Cite this

Synergistic effect of polyoxometalates in combination with oxacillin against methicillin-resistant and vancomycin-resistant Staphylococcus aureus : a high initial inoculum of 1 × 108 cfu/ml for in vivo test. / Inoue, M.; Suzuki, T.; Fujita, Y.; Oda, M.; Matsumoto, N.; Iijima, J.; Yamase, T.

In: Biomedicine and Pharmacotherapy, Vol. 60, No. 5, 06.2006, p. 220-226.

Research output: Contribution to journalArticle

@article{741ab448427e44b3bc3a8733a10c895f,
title = "Synergistic effect of polyoxometalates in combination with oxacillin against methicillin-resistant and vancomycin-resistant Staphylococcus aureus: a high initial inoculum of 1 × 108 cfu/ml for in vivo test",
abstract = "Synergistic effect of polyoxometalates, K6[P2W18O62]·14H 2O (P2W18), K4[SiMo12O40]·3H2O (SiMo12), K7[PTi2W10O40]·6H 2O (PTi2W10), and K9H5[α-Ge2Ti6W18 O77]·16H2O (Ge2Ti6W18), in combination with a β-lactam oxacillin against methicillin-resistant and vancomycin-resistant Staphylococcus aureus (characterized by possessing the penicillin-binding protein 2′ (PBP2′) as a cell-wall synthesis enzyme) with a high initial inoculum of 1 × 108 cfu/ml (for in vivo test) was investigated with a help of the growth curve and the reverse transcription polymerase chain reaction (RT-PCR) analyses. The growth curves showing the suppression of cell proliferation of the strains based on the synergistic effect of the polyoxometalates in combination with oxacillin indicated a recovery of the cell proliferation during continuous cultivation. The duration of the suppression of the cell proliferation increased with increasing the concentration of the polyoxometalates, depending on the amounts of the initial inoculum of the strain. The RT-PCR results for P2W18, SiMo12, and PTi2W10 indicated the suppression of expression of the PBP2′-encoding mecA gene in contrast to the ones for Ge2Ti6W18. The difference in the RT-PCR results among the polyoxometalates suggests that there remain other factors for the inhibition of PBP2′ production such as post-transcription process.",
keywords = "High initial inoculum, MRSA, Polyoxometalates, VRSA",
author = "M. Inoue and T. Suzuki and Y. Fujita and M. Oda and N. Matsumoto and J. Iijima and T. Yamase",
year = "2006",
month = "6",
doi = "10.1016/j.biopha.2006.04.006",
language = "English",
volume = "60",
pages = "220--226",
journal = "Biomedicine and Pharmacotherapy",
issn = "0753-3322",
publisher = "Elsevier Masson",
number = "5",

}

TY - JOUR

T1 - Synergistic effect of polyoxometalates in combination with oxacillin against methicillin-resistant and vancomycin-resistant Staphylococcus aureus

T2 - a high initial inoculum of 1 × 108 cfu/ml for in vivo test

AU - Inoue, M.

AU - Suzuki, T.

AU - Fujita, Y.

AU - Oda, M.

AU - Matsumoto, N.

AU - Iijima, J.

AU - Yamase, T.

PY - 2006/6

Y1 - 2006/6

N2 - Synergistic effect of polyoxometalates, K6[P2W18O62]·14H 2O (P2W18), K4[SiMo12O40]·3H2O (SiMo12), K7[PTi2W10O40]·6H 2O (PTi2W10), and K9H5[α-Ge2Ti6W18 O77]·16H2O (Ge2Ti6W18), in combination with a β-lactam oxacillin against methicillin-resistant and vancomycin-resistant Staphylococcus aureus (characterized by possessing the penicillin-binding protein 2′ (PBP2′) as a cell-wall synthesis enzyme) with a high initial inoculum of 1 × 108 cfu/ml (for in vivo test) was investigated with a help of the growth curve and the reverse transcription polymerase chain reaction (RT-PCR) analyses. The growth curves showing the suppression of cell proliferation of the strains based on the synergistic effect of the polyoxometalates in combination with oxacillin indicated a recovery of the cell proliferation during continuous cultivation. The duration of the suppression of the cell proliferation increased with increasing the concentration of the polyoxometalates, depending on the amounts of the initial inoculum of the strain. The RT-PCR results for P2W18, SiMo12, and PTi2W10 indicated the suppression of expression of the PBP2′-encoding mecA gene in contrast to the ones for Ge2Ti6W18. The difference in the RT-PCR results among the polyoxometalates suggests that there remain other factors for the inhibition of PBP2′ production such as post-transcription process.

AB - Synergistic effect of polyoxometalates, K6[P2W18O62]·14H 2O (P2W18), K4[SiMo12O40]·3H2O (SiMo12), K7[PTi2W10O40]·6H 2O (PTi2W10), and K9H5[α-Ge2Ti6W18 O77]·16H2O (Ge2Ti6W18), in combination with a β-lactam oxacillin against methicillin-resistant and vancomycin-resistant Staphylococcus aureus (characterized by possessing the penicillin-binding protein 2′ (PBP2′) as a cell-wall synthesis enzyme) with a high initial inoculum of 1 × 108 cfu/ml (for in vivo test) was investigated with a help of the growth curve and the reverse transcription polymerase chain reaction (RT-PCR) analyses. The growth curves showing the suppression of cell proliferation of the strains based on the synergistic effect of the polyoxometalates in combination with oxacillin indicated a recovery of the cell proliferation during continuous cultivation. The duration of the suppression of the cell proliferation increased with increasing the concentration of the polyoxometalates, depending on the amounts of the initial inoculum of the strain. The RT-PCR results for P2W18, SiMo12, and PTi2W10 indicated the suppression of expression of the PBP2′-encoding mecA gene in contrast to the ones for Ge2Ti6W18. The difference in the RT-PCR results among the polyoxometalates suggests that there remain other factors for the inhibition of PBP2′ production such as post-transcription process.

KW - High initial inoculum

KW - MRSA

KW - Polyoxometalates

KW - VRSA

UR - http://www.scopus.com/inward/record.url?scp=33745684768&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745684768&partnerID=8YFLogxK

U2 - 10.1016/j.biopha.2006.04.006

DO - 10.1016/j.biopha.2006.04.006

M3 - Article

VL - 60

SP - 220

EP - 226

JO - Biomedicine and Pharmacotherapy

JF - Biomedicine and Pharmacotherapy

SN - 0753-3322

IS - 5

ER -